Market Movers Today: Dermira Inc (DERM), Intrepid Potash, Inc. (IPI), XL Group Ltd (XL), Sparton Corporation (SPA), and More
In a major surprise for Dermira Inc. and Wall Street alike, Dermira’s acne drug failed to meet the co-primary endpoints of two important, late-stage clinical trials.